+660.9%
SNPS vs THC
+1,813.2%
-1,152.3%
-43.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.6% | -0.3% | -1.3% | -1.6% |
| 7D | +1.1% | +1.0% | +0.1% | +0.9% |
| 30D | -5.2% | +5.3% | -10.5% | -5.9% |
| 3M | +10.6% | +7.1% | +3.4% | +9.2% |
| 6M | -10.6% | +46.0% | -56.7% | -16.1% |
| YTD | -3.1% | +43.9% | -47.0% | -9.4% |
| 1Y | +15.6% | +45.4% | -29.9% | +7.7% |
| 3Y | -12.9% | +421.3% | -434.2% | -33.3% |
| 5Y | +31.2% | +261.5% | -230.3% | +3.1% |
| All | +660.9% | +1,813.2% | -1,152.3% | +384.3% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling